Hanson & Doremus Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $350K | Hold |
5,076
| – | – | 0.05% | 148 |
|
|
2025
Q1 | $352K | Hold |
5,076
| – | – | 0.05% | 144 |
|
|
2024
Q4 | $437K | Buy |
5,076
+5,000
| +6,579% | +$430K | 0.07% | 115 |
|
|
2024
Q3 | $9K | Hold |
76
| – | – | ﹤0.01% | 400 |
|
|
2024
Q2 | $11K | Hold |
76
| – | – | ﹤0.01% | 404 |
|
|
2024
Q1 | $10K | Buy |
76
+70
| +1,167% | +$9.21K | ﹤0.01% | 403 |
|
|
2023
Q4 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 459 |
|